Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Hairy cell leukemia in father and son.
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. N Engl J Med. 2019 10 31; 381(18):1728-1740.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Aniline Compounds
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Female
fms-Like Tyrosine Kinase 3
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute
Liver
Male
Middle Aged
Mutation
Pyrazines
Recurrence
Remission Induction
Salvage Therapy
Survival Analysis
authors with profiles
Richard A. Larson